Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Stefan

Showing results (171-180 of 302) with videos related to

Pageof 31
Sort By:
Metabolism: Clinical and Experimental|March 24, 2009
RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging studyKarsten Müssig, Harald Staiger, Fausto Machicao, et al.
Plos One|September 6, 2007
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell functionHarald Staiger, Fausto Machicao, Norbert Stefan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 14, 2006
Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1Anita M Hennige, Norbert Stefan, Katja Kapp, et al.
Molecular Metabolism|April 13, 2016
Granulocyte colony-stimulating factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humansAnna-Maria Ordelheide, Nadja Gommer, Anja Böhm, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2009
The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivityAxel Haupt, Martina Guthoff, Silke A Schäfer, et al.
Plos One|August 21, 2008
Novel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypesHarald Staiger, Fausto Machicao, Konstantinos Kantartzis, et al.
BMC Medical Genetics|June 11, 2010
Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversionMartin Heni, Axel Haupt, Silke A Schäfer, et al.
Molecular Metabolism|June 3, 2021
Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistanceSebastian Hörber, Rainer Lehmann, Norbert Stefan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 4, 2021
Lifestyle Intervention Improves Prothrombotic Coagulation Profile in Individuals at High Risk for Type 2 DiabetesSebastian Hörber, Rainer Lehmann, Louise Fritsche, et al.
The Journal of Clinical Endocrinology and Metabolism|April 15, 2011
Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humansAndreas Peter, Norbert Stefan, Alexander Cegan, et al.
Pageof 31

Showing results (171-180 of 302) with videos related to

Sort By:
Pageof 31
Metabolism: Clinical and Experimental|March 24, 2009
RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging studyKarsten Müssig, Harald Staiger, Fausto Machicao, et al.
Plos One|September 6, 2007
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell functionHarald Staiger, Fausto Machicao, Norbert Stefan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 14, 2006
Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1Anita M Hennige, Norbert Stefan, Katja Kapp, et al.
Molecular Metabolism|April 13, 2016
Granulocyte colony-stimulating factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humansAnna-Maria Ordelheide, Nadja Gommer, Anja Böhm, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2009
The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivityAxel Haupt, Martina Guthoff, Silke A Schäfer, et al.
Plos One|August 21, 2008
Novel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypesHarald Staiger, Fausto Machicao, Konstantinos Kantartzis, et al.
BMC Medical Genetics|June 11, 2010
Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversionMartin Heni, Axel Haupt, Silke A Schäfer, et al.
Molecular Metabolism|June 3, 2021
Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistanceSebastian Hörber, Rainer Lehmann, Norbert Stefan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 4, 2021
Lifestyle Intervention Improves Prothrombotic Coagulation Profile in Individuals at High Risk for Type 2 DiabetesSebastian Hörber, Rainer Lehmann, Louise Fritsche, et al.
The Journal of Clinical Endocrinology and Metabolism|April 15, 2011
Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humansAndreas Peter, Norbert Stefan, Alexander Cegan, et al.
Pageof 31